Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy
Go back to Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.42 +1.30 (2.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.12 | 52 Week High | $59.00 | |||
| Open | $46.05 | 52 Week Low | $32.80 | |||
| Day High | $46.94 | P/E | N/A | |||
| Day Low | $45.91 | EPS | $0.00 | |||
| Volume | 5,211,706 | |||||
